PET imaging of PARP-1 expression in breast cancer

被引：0

作者：

McDonald, E. S. ^{[1
]}

Carlin, S. ^{[1
]}

Maxwell, K. N. ^{[1
]}

Nayak, A. ^{[1
]}

Doot, R. K. ^{[1
]}

Pantel, A. R. ^{[1
]}

Farwell, M. D. ^{[1
]}

Pryma, D. A. ^{[1
]}

Clark, A. S. ^{[1
]}

Shah, P. ^{[1
]}

DeMichele, A. M. ^{[1
]}

Ziober, A. ^{[1
]}

Schubert, E. K. ^{[1
]}

Palmer, K. ^{[1
]}

Lee, H. S. ^{[1
]}

Matro, J. ^{[1
]}

de la Cruz, L. ^{[1
]}

Tchou, J. ^{[1
]}

Anderson, D. N. ^{[1
]}

Feldman, M. D. ^{[1
]}

Sheffer, R. E. ^{[1
]}

Knollman, H. ^{[1
]}

Schnall, M. D. ^{[1
]}

Makvandi, M. ^{[1
]}

Domchek, S. ^{[1
]}

Hubbard, R. A. ^{[1
]}

Mach, R. H. ^{[1
]}

Mankoff, D. A. ^{[1
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 04期

关键词：

D O I：

10.1158/1538-7445.SABCS18-PD4-07

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PD4-07

引用

页数：2

共 50 条

[1] Exploring the significance of PARP-1 expression for therapy and clinical PET/CT imaging of PARP-1 in ovarian cancer
Makvandi, Mehran
Pantel, Austin
Schwartz, Lauren E.
Xu, Kuiying
Hsieh, Chia-Ju
Kim, Hyoung
Li, Shi-Hong
Doot, Robert
Lee, Sharon
Simpkins, Fiona
Greenberg, Roger A.
Mankoff, David A.
Mach, Robert H.
Lin, Lilie
CANCER RESEARCH, 2017, 77
[2] A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Makvandi, Mehran
Pantel, Austin
Schwartz, Lauren
Schubert, Erin
Xu, Kuiying
Hsieh, Chia-Ju
Hou, Catherine
Kim, Hyoung
Weng, Chi-Chang
Winters, Harrison
Doot, Robert
Farwell, Michael D.
Pryma, Daniel A.
Greenberg, Roger A.
Mankoff, David A.
Simpkins, Fiona
Mach, Robert H.
Lin, Lilie L.
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (05): : 2116 - 2126
[3] Synthesis and evaluation of a novel 18F labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer
Zhou, Dong
Xu, Jinbin
Chu, Wenhua
Kim, Sung Hoon
Rogers, Buck
Katzenellenbogen, John
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[4] Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer
Zhou, Dong
Xu, Jinbin
Mpoy, Cedric
Chu, Wenhua
Kim, Sung Hoon
Li, Huifangjie
Rogers, Buck E.
Katzenellenbogen, John A.
NUCLEAR MEDICINE AND BIOLOGY, 2018, 66 : 26 - 31
[5] Novel PARP-1 PET/CT imaging in Pheochromocytoma and Paraganglioma
Wachtel, Heather
Pantel, Austin
Bonanni, Maria
Bennett, Bonita
Cohen, Debbie L.
Eads, Jennifer
Narayan, Vivek
Nathanson, Katherine
Pryma, Daniel
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S58 - S58
[6] Current status and progress in using radiolabelled PARP-1 inhibitors for imaging PARP-1 expression in tumours
Wang, Qianna
Zhang, Junbo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 242
[7] PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients' CTCs
Sklias, Thodoris
Vardas, Vasileios
Pantazaka, Evangelia
Christopoulou, Athina
Georgoulias, Vassilis
Kotsakis, Athanasios
Vasilopoulos, Yiannis
Kallergi, Galatea
CANCERS, 2022, 14 (07)
[8] PET imaging of PARP-1 expression using a novel 18F-labeled Olaparib
Zou, Yuheng
Wang, Hui
Hu, Mingxing
Chen, Wei
Tian, Rong
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
[9] 18F-radiolabeled PARP-1 inhibitor uptake as a marker of PARP-1 activity in breast cancer
Edmonds, C. E.
Lieberman, B. P.
Xu, K.
Zeng, C.
Makvandi, M.
Li, S.
Hou, C.
Lee, H.
Greenberg, R. A.
Mankoff, D. A.
Mach, R. H.
CANCER RESEARCH, 2016, 76
[10] Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression
Xiaobin Ma
Chengxue Dang
Weili Min
Yan Diao
Wentao Hui
Xiaolong Wang
Zhijun Dai
Xijing Wang
Huafeng Kang
Breast Cancer Research and Treatment, 2019, 176 : 109 - 117

← 1 2 3 4 5 →